Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Osteosarcoma mechanobiology and therapeutic targets
Zunaira Shoaib, Timothy M. Fan, Joseph Irudayaraj
British Journal of Pharmacology (2021) Vol. 179, Iss. 2, pp. 201-217
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Ruiqi Liu, Jiajun Wu, H. Henry Guo, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 104
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Pengzhi Shi, Zhangrong Cheng, Kangcheng Zhao, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 75
Advances in Osteosarcoma
Isidora Panez-Toro, Javier Muñoz-García, Jorge William Vargas-Franco, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 4, pp. 330-343
Open Access | Times Cited: 71
Tantalum–Zirconium Co‐Doped Metal–Organic Frameworks Sequentially Sensitize Radio–Radiodynamic–Immunotherapy for Metastatic Osteosarcoma
Tao Li, Mingquan Gao, Zifei Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 46
Circ‐CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15
Feng Yang, Yang Liu, Jun Xiao, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 48
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Yujing Guan, Wei Zhang, Yuling Mao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential
Yongfei Fan, Xinwei Li, Huihui Sun, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1224-1224
Open Access | Times Cited: 30
Anti-Invasive and Anti-Migratory Effects of Ononin on Human Osteosarcoma Cells by Limiting the MMP2/9 and EGFR-Erk1/2 Pathway
Guowei Gong, Kumar Ganesan, Qingping Xiong, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 758-758
Open Access | Times Cited: 20
Mitochondria targeted biomimetic platform for chemo/photodynamic combination therapy against osteosarcoma
Fengtian Zhang, Jiaoting Chen, Weihong Luo, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123865-123865
Closed Access | Times Cited: 7
Bone and Joint‐on‐Chip Platforms: Construction Strategies and Applications
Chengcheng Du, Jiacheng Liu, Senrui Liu, et al.
Small Methods (2024)
Closed Access | Times Cited: 6
Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism
Jiaxin Ren, Cheng Zhao, Ruizhu Sun, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 9, pp. 1626-1638
Closed Access | Times Cited: 5
Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
Jianghu Zhou, Fengjun Lan, Miao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
Zhun Wei, Kezhou Xia, Di Zheng, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 12
Comprehensive Analysis of FBXO43 Expression and Its Prognostic and Therapeutic Implications in Osteosarcoma
Jiang Jin, Yao Kang, Tingxiao Zhao, et al.
International Journal of Clinical Practice (2025) Vol. 2025, Iss. 1
Open Access
Inhibition of id-1 reduces osteosarcoma growth and metastasis through mediation of snail
Rongbing Shu, Zhuanyi Yu, Jianmin Wu, et al.
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access
Bone microphysiological models for biomedical research
Francisco Verdugo-Avello, Jacek K. Wychowaniec, Carlos A. Villacis-Aguirre, et al.
Lab on a Chip (2025)
Open Access
ZFP36 promotes ferroptosis and mitochondrial dysfunction and inhibits malignant progression in osteosarcoma by regulating the E2F1/ATF4 axis
Shiyue Qin, Hongyang Kong, Lei Jiang
Journal of Pharmaceutical Analysis (2025), pp. 101228-101228
Open Access
Efficacy and safety of regorafenib in the treatment of bone sarcomas: systematic review and meta-analysis
Yuanhang Han, Jiangtao Xie, Yuyang Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway
Wenda Liu, Kezhou Xia, Xinghan Huang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
A m6A writer RBM15 enhances the cell malignancy of osteosarcoma by mediating m6A modification of lncRNA THAP9-AS1
Hao Zou, Fei Hu, Xin Wu, et al.
Experimental Cell Research (2025), pp. 114490-114490
Closed Access
Genetically predicted plasma metabolites mediate the causal relationship between gut microbiota and osteosarcoma
Xiuyu Qin, Zhuming Fan, Shigang Qiao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Erianin Induces Apoptosis of Osteosarcoma Cells Through Ferroptosis Signaling Pathway, and Inhibits Proliferation and Migration of Osteosarcoma Cells
Beilei Yu, Shu Feng, Zhongzhe Li, et al.
Research Square (Research Square) (2025)
Closed Access
CCCTC-binding factor regulates splicing factor proline and glutamine-rich to promote malignant growth of osteosarcoma
Dapeng Li, Yang Yang, Zhengyu Yin, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1495-1509
Closed Access
Biological Activity of Biomarkers Associated With Metastasis in Osteosarcoma Cell Lines
Nidia Ednita Beltrán‐Hernández, Luis Cárdenas, Verónica Jiménez‐Jacinto, et al.
Cancer Medicine (2025) Vol. 14, Iss. 6
Open Access
Page 1 - Next Page

Scroll to top